* Includes only unique trials
Basic Summary - Pfizer
Product Trial
No. Of Candidates
Product Type
Biomarker/MOA
Indication
Therapeutic Area
Pipeline Candidates
Marketed Drug
Available For Licensing
Biological Class
Patent Expiry
Sales Data ($ MN)
Contact
Clinical Trial Result
Basic Analysis
Current Development Phase
*
Includes only unique trials
* Highest Phase based on
Product+Indication
Indication Analysis
*
Includes only unique trials
* Top 8 based on Product,
Indication & Phase
Therapeutic Area
*
Includes only unique trials
* Top 8 Therapeutic Area based on
Sponsor
Prediction Of Launch
* Based on
Product,Indication.
* Next five year projection only.
Sponsor Level Competition
* Sponsor listed based on Indication
Country Wise Analysis
* Country Wise Analysis
Probable Licensing Opportunity
*Total number based on
Product,Indication and Phase
*
Includes only unique trials
Expedited Program
* Includes only unique trials
Product Level Analysis
| Sponsors | Product Count |
|---|---|
| Loading... | Loading... |
| Loading... | Loading... |
| Loading... | Loading... |
| Loading... | Loading... |
| Loading... | Loading... |
| Loading... | Loading... |
* Top 10 product count by Sponsor
Country
Trial Id
Start Date
Completion Date
Study Title
Product
Product Type
Biological Class
Industry Type
Biomarker/MOA
Indication
Therapeutic Area
Orignal Trial Phase
Current Dev Phase
Approved/Unapproved(NDA)
Trial Status
Patent Expiry
Terminated Reason
Outcome Measures
Sponsor/Collaborator
Primary Sponsor
Sponsor Type
Sponsor Classification
Licensing Opportunity
ODD/FTA/BTA
Study Design
Study Type
Synonym
| Country | Trial ID | Start Date | Completion Date | Study Title | Product | Primary Product | Synonym | Product Type | Biological Class (If any) | Industry Type | Biomarker/MOA | Indication | Therapeutic Area | Original Trial Phase | Current Development Phase | Marketing Status | Trial Status | Prediction Of Launch | Patent Expiry Date | Sales Data ($ MN) 2023 | Terminated Reason | Outcome Measures | Clinical Trial Result | Sponsor/Collaborator | Primary Sponsor | Sponsor Type | Sponsor Classification | Probable Licensing Opportunity | Expedited Program | Contact Details | Gender | Age | Population Size | Study Design | Study Type | First Posted | Results First Posted | Last Update Posted | Location |
|---|
- US Data from January 2000 to May 2025
- Europe Data from January 2023 to September 2025
- Japan Data from January 2005 to March 2025
- Canada Data from December 2003 to September 2025
- Aus/NZ Data from January 2005 to May 2025
- Korea Data from April 2010 to July 2025
- India Data from August 2007 to March 2025